BDZ-g

CAS No. 732278-52-3

BDZ-g( —— )

Catalog No. M35613 CAS No. 732278-52-3

BDZ-g is a potent and selective antagonist of AMPA receptor. BDZ-g can be used for the research of various neurological disorders involving excessive activity of AMPA receptors.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 178 In Stock
5MG 255 In Stock
10MG 374 In Stock
25MG 545 In Stock
50MG 762 In Stock
100MG 1017 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BDZ-g
  • Note
    Research use only, not for human use.
  • Brief Description
    BDZ-g is a potent and selective antagonist of AMPA receptor. BDZ-g can be used for the research of various neurological disorders involving excessive activity of AMPA receptors.
  • Description
    BDZ-g is a potent, selective antagonist of AMPA receptor. BDZ-g has the potential for the research of various neurological disorders involving excessive activity of AMPA receptors.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    iGluR
  • Recptor
    iGluR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    732278-52-3
  • Formula Weight
    407.49
  • Molecular Formula
    C21H21N5O2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC=1C=C(C=2C3=C(C=C4C(=C3)OCO4)C[C@@H](C)N(N2)C=5SC(C)=NN5)C=CC1N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Wang C, et al. Mechanism and site of inhibition of AMPA receptors: pairing a thiadiazole with a 2,3-benzodiazepine scaffold. ACS Chem Neurosci. 2014;5(2):138-147.?
molnova catalog
related products
  • S44819

    S44819 (S-44819, Egis-1352 Afizagabar) is a novel potent, competitive, selective antagonist of the α5-GABAAR with Kd of 221 nM, IC50 of 585 nM (α5β2γ2).

  • Gavestinel sodium

    Gavestinel (GV 150526) is a non-competitive NMDA receptor antagonist that is potent, selective and orally active.

  • CP 465022

    CP 465022 hydrochloride is a potent, and selective noncompetitive antagonist of AMPA receptor with anticonvulsant activity.